By G HossainPosted on August 20, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Investors had been pessimistic about the probability of success for the personalized cancer vaccine intismeran autogene, so the Phase 3 win was a welcome surprise. Merck’s Moderna-partnered vaccine success clears view of post-Keytruda future Post navigation 7 biopharma M&A deals where layoffs followedUltragenyx bags first gene therapy approval as previously rejected Sanfilippo asset awaits decision